VivoSeq
Other

Oxygenation

0

Pipeline Programs

5

Active Trials

4

Companies Involved

Oxygenation is an early-stage landscape with 0 programs across 4 companies. The most active players are Boehringer Ingelheim, Pfizer, Global Blood Therapeutics.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

8/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

37

clinical trials

Completed23 · 62%
Unknown status6 · 16%
Recruiting2 · 5%
Withdrawn2 · 5%
Not yet recruiting2 · 5%
Terminated1 · 3%
Other1 · 3%

Trial Activity

37 trials

Effect of Maternal and Neonatal Oxygenation
Completed·MMahidol University·Phase 3·NCT01530971·325 enrolled
Fluid Filled Lung Oxygenation Assistance Trial
Completed··Phase 1·NCT03041740·16 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)